Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

(NASDAQ:CRNX), SAN DIEGO, Oct. 06, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report third quarter 2025 financial results on Thursday, November 6, 2025 after the market closes. Company management will host a conference call at 4:30 p.m. ET to discuss financial results and provide a business update. Conference […]

Encore Capital Group to Announce Third Quarter 2025 Financial Results on November 5

(NASDAQ:ECPG), SAN DIEGO, Oct. 06, 2025 (GLOBE NEWSWIRE) — Encore Capital Group, Inc. (Nasdaq:ECPG), an international specialty finance company, announced today that it will release its financial results for the third quarter 2025 on Wednesday, November 5, 2025, after the market closes. The Company will also host a conference call and slide presentation the same

Tile Shop’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock

(NASDAQ:TTSH), MINNEAPOLIS, Oct. 06, 2025 (GLOBE NEWSWIRE) — Tile Shop Holdings, Inc. (Nasdaq: TTSH) (“Tile Shop” or the “Company”), a specialty retailer of natural stone, man-made and luxury vinyl tiles, setting and maintenance materials and related accessories, today announced that the Independent Transaction Committee (the “Transaction Committee”) of the Board of Directors of the Company

Preferred Bank Announces 2025 Third Quarter Earnings Release and Conference Call

(NASDAQ:PFBC), LOS ANGELES, Oct. 06, 2025 (GLOBE NEWSWIRE) — Preferred Bank (NASDAQ: PFBC), one of the larger independent commercial banks in California, today announced plans to release its financial results for the third quarter ended September 30, 2025 after the close of market on Monday, October 20, 2025. On the following day, Tuesday, October 21,

NN, Inc. Provides Update on Aerospace and Defense Capabilities

(NASDAQ:NNBR), Company Also Announces a New Weapons Customer for its North American Machining Operations CHARLOTTE, N.C., Oct. 06, 2025 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, today provided an update on its Aerospace and Defense business, supported by registration with the U.S.

Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update

(NYSE MKT:SENS), Preliminary unaudited revenue of $8.1 million for Q3 2025 Generated record quarterly new patient starts in Q3 2025 Established reverse stock split ratio of 1:20, anticipated to be effective October 17, 2025 GERMANTOWN, Md., Oct. 06, 2025 (GLOBE NEWSWIRE) — Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the

Armada Hoffler to Report Third Quarter Earnings on November 3rd

(NYSE:AHH), VIRGINIA BEACH, Va., Oct. 06, 2025 (GLOBE NEWSWIRE) — Armada Hoffler (NYSE: AHH) will report its earnings for the quarter ending September 30, 2025 at approximately 4:00 p.m. Eastern on Monday, November 3, 2025. At 8:30 a.m. Eastern on Tuesday, November 4, 2025, senior management will host a conference call and webcast to discuss

Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales

(NasdaqGM:VRNA), LONDON and RALEIGH, N.C., Oct. 06, 2025 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive agreement on July 8, 2025 relating to its proposed acquisition by MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA), known as Merck in

Sprout Social to Announce Third Quarter 2025 Financial Results on November 5, 2025

(NASDAQ:SPT), CHICAGO, Oct. 06, 2025 (GLOBE NEWSWIRE) — Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced that it will report its financial results for the third quarter ending September 30, 2025 after market close on Wednesday, November 5, 2025. The financial results and

Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025 GlobeNewswire October 06, 2025 SAN DIEGO, Oct. 06, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report third quarter 2025 financial results on Thursday, November 6, 2025 after the market closes. Company management will host a

Scroll to Top